Master Services AgreementMaster Services Agreement • October 6th, 2020 • GT Biopharma, Inc. • Pharmaceutical preparations • Delaware
This Master Services Agreement (this “Agreement”), effective October 5, 2020 (the “Effective Date”), is between GT Biopharma, Inc. (“Client”), a Delaware corporation having a place of business at 9350 Wilshire Blvd., Suite 203, Beverly Hills, CA 90212, and Cytovance Biologics, Inc. (“Cytovance”), a Delaware corporation having a place of business at 800 Research Parkway, Suite 200, Oklahoma City, OK 73104. Client and Cytovance are each referred to as a “Party” and collectively referred to as the “Parties”.
